MILLER AINE (SVP, DEV & HEAD OF IRE OFFICE) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 8/22/2025ACC: 0001415889-25-022799
Officer· SVP, DEV & HEAD OF IRE OFFICE
Since Feb 2026
-6.99K
Net shares
Net seller
$93.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.99K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−6.99K
Price / share
$13.39
Trade value
$93.58K
% of position
3.3%
8/20/2025
214.99K→208K
Total
Net shares
−6.99K
Net value
-$93.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/20/2025 | F · Tax Withholding | −6.99K | $13.39 | $93.58K | 3.3% | 214.99K | 208K |
| Total | −6.99K | -$93.58K | ||||||
Derivative Transactions0
No derivative transactions reported